http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200940065-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-18 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-18 |
filingDate | 2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5070e80287448225d580f3b31bd47b65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3699f5da516a31d1449c76fa188c082c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c485608534eca5d67ed1bdec00c781fb |
publicationDate | 2009-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-200940065-A |
titleOfInvention | Crystalline, enantiomerically pure salt of a beta-agonist and the use thereof as a drug |
abstract | The present invention relates to a crystalline, enantiomerically pure hydrochloride salt of N-(5-{2-[3-(4, 4-diethyl-2-oxo-4H-benzo[d][1, 3]oxazin-1-yl)-1, 1-dimethyl-propylamino]-1-hydroxy-ethyl}-2-hydroxy-phenyl)-methanesulphonamide, preferably N-(5-{(R)-2-[3-(4, 4-diethyl-2-oxo-4H-benzo[d][1, 3]oxazin-1-yl)-1, 1-dimethyl-propylamino]-1-hydroxy-ethyl}-2-hydroxy-phenyl)-methanesulphonamide and its activity as a long-acting betamimetic, on its own or in conjunction with one or more other active substances for the treatment of respiratory complaints. |
priorityDate | 2008-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 263.